---
title: "ATYR Pharma (ATYR.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ATYR.US/norm.md"
symbol: "ATYR.US"
name: "ATYR Pharma"
parent: "https://longbridge.com/zh-CN/quote/ATYR.US.md"
datetime: "2026-05-20T04:34:51.136Z"
locales:
  - [en](https://longbridge.com/en/quote/ATYR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ATYR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ATYR.US/norm.md)
---

# ATYR Pharma (ATYR.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1101 | -0.1425 | -0.2650 | -0.2167 | -0.1721 |
| ROE | -68.83% | -75.62% | -132.80% | -104.24% | -82.06% |
| 营业收入 | - | 0.0000 | 190000.00 | - | - |
| 净利润 | -10.79M | -13.96M | -25.74M | -19.53M | -14.88M |
| 营业利润 | -11.44M | -14.80M | -26.75M | -20.31M | -15.77M |
| 毛利率 | - | - | -11547.37% | - | - |
| 净利率 | - | - | -13549.47% | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 79.65M | 93.00M | 106.65M | 101.53M | 97.25M |
| 权益乘数 | 1.38 | 1.38 | 1.33 | 1.36 | 1.30 |
| 每股净资产 | 0.5909 | 0.6884 | 0.8188 | 0.8059 | 0.8432 |
| 资产周转率 | 0.0021 | 0.0020 | 0.0019 | 0.0000 | 0.0000 |
| 现金及短投 | 66.51M | 78.69M | 90.20M | 80.35M | 76.35M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 10.13M | 10.38M | 10.78M | 11.10M | 11.48M |
| 净债务 | -54.81M | -66.65M | -77.84M | -67.67M | -63.36M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -12.52M | -12.20M | -20.48M | -13.89M | -15.42M |
| 投资现金流 | 11.49M | 16.44M | -20.38M | 3.30M | -4.42M |
| 融资现金流 | -142000.00 | -131000.00 | 29.62M | 17.90M | 18.63M |
| 自由现金流 | -8.57M | -6.98M | -10.67M | -6.43M | -9.71M |
| 现金流充裕率 | -4470.36% | -7174.12% | -11835.84% | -9784.51% | -11770.99% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -138000.00 | -31000.00 | -37000.00 | -9000.00 | - |